Company intelligence / Profile preview

Epitopoietic Research Corporation

Ownership: Private
Development stage: Other

Overview

ERC’s regimen of therapeutic vaccines has shown early promise in patients suffering from recurrent Glioblastoma multiforme... In the US, treatment has been provided under the Federal Right-to-Try law. Clinical trials are ongoing.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Cell therapyVaccine (therapeutic cancer vaccine)Biologic
Industry: Biotech

Partnerships

Not publicly disclosed; collaborates with leading clinicians globally including US and Europe

Beyond the preview

Go deeper on Epitopoietic Research Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epitopoietic Research Corporation.

Explore the full profile